IP Library Patent Application 14721014
Patent Application
App. No. 14/721,014

HUMAN THERAPEUTIC AGENTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/721,014
Abstract

Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.

Claims (16)

1 . A therapeutic composition comprising the combination of at least one curcumin component comprising curcumin and at least one harmine component comprising harmine, wherein the components of the composition are different, said at least one curcumin component being synthetically derived or derived from naturally occurring product(s) containing said at least one curcumin component which have been treated so that the at least one curcumin component is present at a level of at least about 25% by weight in the treated naturally occurring product(s), and said at least one harmine component being synthetically derived or derived from naturally occurring product(s) containing said at least one harmine component which have been treated so that the at least one harmine component is present at a level of at least about 25% by weight in the treated naturally occurring product(s).

2 . The composition of claim 1 , wherein said curcumin and said harmine are each at least about 70% pure.

3 . The composition of claim 1 , the weight ratio of said curcumin to said harmine ranging from about 0.01:1 to 10:1.

4 . The composition of claim 1 , the weight amount of said harmine being from about 30-55% by weight, and the weight amount of said harmine being from about 70-45% by weight, based upon the total weight of the two components taken as 100% by weight.

5 . (canceled)

6 . (canceled)

7 . (canceled)

8 . (canceled)

9 . (canceled)

10 . The composition of claim 1 , wherein the composition exhibits therapeutic synergy.

11 . (canceled)

12 . (canceled)

13 . (canceled)

14 . (canceled)

15 . (canceled)

16 . The composition of claim 1 , said at least one curcumin component consisting essentially of curcumin, and said at least one component consisting essentially of harmine.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2016
From: GENZADA PHARMACEUTICALS LLC
To: IONS PHARMACEUTICAL S.À R.L.
Reel/Frame 039018/0259 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE INCORRECTLY SET FORTH AS AN ASSIGNMENT, CORRECTED TO CHANGE OF NAME PREVIOUSLY RECORDED ON REEL 036800 FRAME 0858. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jun 13, 2016
From: LIFE PLUS, LLC
To: GENZADA PHARMACEUTICALS LLC
Reel/Frame 038980/0983 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2015
From: LIFE PLUS, LLC
To: GENZADA PHARMACEUTICALS LLC
Reel/Frame 036800/0858 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA PREVIOUSLY RECORDED AT REEL: 035713 FRAME: 0460. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 19, 2015
From: ZAID, GENE H.; BURGOYNE, THOMAS W.
To: LIFE PLUS, LLC
Reel/Frame 036499/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2015
From: ZAID, GENE H.
To: LIFE PLUS, LLC
Reel/Frame 035713/0460 →